125 related articles for article (PubMed ID: 10197844)
1. Heritability of the symptoms of benign prostatic hyperplasia and the roles of age and zonal prostate volumes in twins.
Meikle AW; Bansal A; Murray DK; Stephenson RA; Middleton RG
Urology; 1999 Apr; 53(4):701-6. PubMed ID: 10197844
[TBL] [Abstract][Full Text] [Related]
2. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Rademaker A; Lloyd GL; Gann P
J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
[TBL] [Abstract][Full Text] [Related]
3. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
4. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
Meikle AW; Stephenson RA; Lewis CM; Wiebke GA; Middleton RG
Prostate; 1997 Oct; 33(2):105-11. PubMed ID: 9316651
[TBL] [Abstract][Full Text] [Related]
5. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume.
Terris MK; Afzal N; Kabalin JN
Urology; 1998 Sep; 52(3):462-6. PubMed ID: 9730461
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
8. Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins.
Bansal A; Murray DK; Wu JT; Stephenson RA; Middleton RG; Meikle AW
J Clin Endocrinol Metab; 2000 Mar; 85(3):1272-6. PubMed ID: 10720075
[TBL] [Abstract][Full Text] [Related]
9. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia.
Eckhardt MD; van Venrooij GE; Boon TA
Urology; 2001 Dec; 58(6):966-71. PubMed ID: 11744470
[TBL] [Abstract][Full Text] [Related]
10. Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia.
Lepor H; Nieder A; Feser J; O'Connell C; Dixon C
J Urol; 1997 Jul; 158(1):85-8. PubMed ID: 9186329
[TBL] [Abstract][Full Text] [Related]
11. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
[TBL] [Abstract][Full Text] [Related]
12. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.
Kojima M; Naya Y; Inoue W; Ukimura O; Watanabe M; Saitoh M; Watanabe H
J Urol; 1997 Jun; 157(6):2160-5. PubMed ID: 9146607
[TBL] [Abstract][Full Text] [Related]
13. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
Milonas D; Trumbeckas D
Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
18. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
19. Data from frequency-volume charts versus symptom scores and quality of life score in men with lower urinary tract symptoms due to benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Gisolf KW; Boon TA
Eur Urol; 2001 Jan; 39(1):42-7. PubMed ID: 11173938
[TBL] [Abstract][Full Text] [Related]
20. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
